Pathophysiology of Cell Injury Journal "PCIJ" recommends that authors considering submission to journal first read the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical Considerations in the Conduct and Reporting of Research: Conpeting Interests” published by the International Committee of Medical Journal Editors.
Authors must include a ‘Competing interests’ statement in the article. A competing interest will not preclude publication of the article, but it provides full transparency for the referees and readers. If there are no competing interests to declare, the following standard statement is added to the article: ‘No competing interests were disclosed’.
A competing interest may be of non-financial or financial nature. Examples of competing interests include (but are not limited to):
individuals receiving funding, salary or other forms of payment from an organization, or holding stocks or shares from a company, that might benefit (or lose) financially from the publication of the findings;
individuals or their funding organization or employer holding (or applying for) related patents;
official affiliations and memberships with interest groups relating to the content of the article;
political, religious, or ideological competing interests.
Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should declare these as competing interests on submission. The relationship of each author to such an organization should be explained in the ‘Competing interests’ section. Articles published in BM-Publisher journals must not contain content advertising any commercial products.
The International Society for Medical Publication Professionals provides good practice guidelines, which are aimed at ensuring that “clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner”.
